Comprehensive Sickle Cell Center - 747 52nd Street - Oakland, CA 94609
|
Sibling Donor Cord Blood Transplant Study Now Open
The Sibling Donor Cord Blood Program has initiated a clinical trial to investigate the risks and benefits of umbilical cord blood transplantation as a treatment for hemoglobin disorders such as sickle cell anemia and thalassemia major. Dr. Mark Walters of Children’s Hospital Oakland directs the study, titled "Multicenter Investigation of Sibling Donor Cord Blood Transplantation for Treatment of Symptomatic Sickle Cell Disease and β-thalassemia Major." The study aims to assess a new method for performing stem cell transplantation using umbilical cord blood, which may minimize side effects of treatment and increase the chance of curing the underlying disease. To be eligible, children with sickle cell anemia and thalassemia must have experienced health problems related to these disorders, and must have an HLA-identical sibling donor whose cord blood was collected and stored after birth. We look forward to the results of this exciting study. For additional information:
|
-Go back to main menu-
-Go to general information for the Bone Marrow Transplant Program-
 |